Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379673 · ClinicalTrials.gov registry record · NA
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
A NA study of Ventilatory Depression and Postoperative Respiratory Failure, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05379673: Recruiting NA study of Ventilatory Depression and Postoperative Respiratory Failure, sponsored by Stanford University.
NCT05379673 is a NA study of Ventilatory Depression and Postoperative Respiratory Failure that is actively recruiting participants, run by Stanford University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05379673, a NA study of Ventilatory Depression and Postoperative Respiratory Failure, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.
Primary Outcome
The cumulative segment of time during which the transcutaneous partial pressure of carbon dioxide (TcPCO2: primary outcome) will exceed an upper limit of 45 mmHg (i.e., TcPCO2 \> 45 mmHg)
Conditions Studied
Interventions
- OTHER Oxygen Gas for Inhalation
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05379673 shows while recruiting
NCT05379673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Ventilatory Depression appearing as the primary indexed condition, and to 1 intervention - of which Oxygen Gas for Inhalation is the first listed.
NCT05379673 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05379673 about?
NCT05379673 is a clinical study titled "The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia". In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.
What is the current status of trial NCT05379673?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-10-04. Estimated completion is 2026-12.
What conditions does trial NCT05379673 study?
This clinical trial studies the following conditions: Ventilatory Depression, Postoperative Respiratory Failure.
What interventions are being tested in trial NCT05379673?
The interventions under investigation include: Oxygen Gas for Inhalation (OTHER).
Who is sponsoring clinical trial NCT05379673?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05379673 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilatory Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05379673's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI